Aveanna Healthcare Holdings Inc (AVAH)

Currency in USD
7.080
-0.120(-1.67%)
Closed·
7.220+0.140(+1.98%)
·
AVAH Scorecard
Full Analysis
Net income is expected to grow this year
AVAH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.0607.350
52 wk Range
3.6707.615
Key Statistics
Prev. Close
7.2
Open
7.27
Day's Range
7.06-7.35
52 wk Range
3.67-7.615
Volume
999.51K
Average Volume (3m)
855.63K
1-Year Change
41.6%
Book Value / Share
-0.05
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVAH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.750
Downside
-4.66%
Members' Sentiments
Bearish
Bullish
ProTips
7 analysts have revised their earnings upwards for the upcoming period
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Aveanna Healthcare Holdings Inc Company Profile

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Aveanna Healthcare Holdings Inc SWOT Analysis


Legislative Triumphs
Explore Aveanna's proactive approach to state-level advocacy, securing improved reimbursement rates and bolstering its financial outlook
Payor Partnerships
Delve into Aveanna's strategic preferred payor arrangements, enhancing revenue stability and competitive positioning in the home care market
Financial Resilience
Learn how Aveanna's robust performance and raised price targets (up to $5) reflect growing investor confidence despite current profitability challenges
Industry Dynamics
Uncover how Aveanna capitalizes on shifting healthcare trends, navigating regulatory complexities while expanding its home care services portfolio
Read full SWOT analysis

Aveanna Healthcare Holdings Inc Earnings Call Summary for Q2/2025

  • Q2 EPS of $0.18 beat $0.04 forecast; revenue reached $590M, up 16.8% YoY; stock surged 38.77% pre-market
  • Revenue growth driven by strategic acquisitions and service expansions; Private Duty Services up 19.2%
  • 2025 revenue guidance raised to over $2.3B; adjusted EBITDA projected to exceed $270M
  • CEO emphasized strong demand for home care; CFO highlighted importance of preferred payer relationships
  • Challenges include potential Medicare rate cuts, Medicaid budget constraints, and labor market issues
Last Updated: 07/08/2025, 20:18
Read Full Transcript

Compare AVAH to Peers and Sector

Metrics to compare
AVAH
Peers
Sector
Relationship
P/E Ratio
79.7x10.3x−0.5x
PEG Ratio
0.710.360.00
Price/Book
−131.3x2.0x2.6x
Price / LTM Sales
0.7x1.2x3.3x
Upside (Analyst Target)
−8.6%34.2%40.3%
Fair Value Upside
Unlock12.7%5.1%Unlock

Analyst Ratings

2 Buy
4 Hold
2 Sell
Ratings:
8 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 6.750
(-4.66% Downside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
0.18 / 0.04
Revenue / Forecast
589.60M / 533.92M
EPS Revisions
Last 90 days

AVAH Income Statement

People Also Watch

2.140
VOR
+8.08%
5.550
TLS
+2.02%
57.81
BMNR
-4.37%
185.85
ALAB
-2.54%
457.85
MEDP
-0.18%

FAQ

What Stock Exchange Does Aveanna Healthcare Holdings Trade On?

Aveanna Healthcare Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Aveanna Healthcare Holdings?

The stock symbol for Aveanna Healthcare Holdings is "AVAH."

What Is the Aveanna Healthcare Holdings Market Cap?

As of today, Aveanna Healthcare Holdings market cap is 1.48B.

What Is Aveanna Healthcare Holdings's Earnings Per Share (TTM)?

The Aveanna Healthcare Holdings EPS (TTM) is 0.09.

When Is the Next Aveanna Healthcare Holdings Earnings Date?

Aveanna Healthcare Holdings will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is AVAH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Aveanna Healthcare Holdings Stock Split?

Aveanna Healthcare Holdings has split 0 times.

How Many Employees Does Aveanna Healthcare Holdings Have?

Aveanna Healthcare Holdings has 33500 employees.

What is the current trading status of Aveanna Healthcare Holdings (AVAH)?

As of 16 Aug 2025, Aveanna Healthcare Holdings (AVAH) is trading at a price of 7.08, with a previous close of 7.20. The stock has fluctuated within a day range of 7.06 to 7.35, while its 52-week range spans from 3.67 to 7.62.

What Is Aveanna Healthcare Holdings (AVAH) Price Target According to Analysts?

The average 12-month price target for Aveanna Healthcare Holdings is USD6.75, with a high estimate of USD9 and a low estimate of USD5. 2 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an -4.66% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.